Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.22
-1.08 (-4.44%)
At close: Nov 20, 2026, 4:00 PM EST
23.17
-0.05 (-0.22%)
After-hours: Nov 20, 2026, 7:30 PM EST
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.44 billion as of November 20, 2026. It is the 7,678th most valuable company in the world and the 1,912th biggest in the United States. Its market cap has increased by 5,227.32% in one year.
Market Cap
1.44B
Enterprise Value
910.05M
1-Year Change
5,227.32%
Global Rank
Country Rank
#1,912 United States
Category
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.44B, an increase of 289.78%. That is a compound annual growth rate of 25.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.44B | 3,810.91% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.46B |
| Vir Biotechnology | 1.44B |
| Kailera Therapeutics | 1.43B |
| Sarepta Therapeutics | 1.43B |
| ADARx Pharmaceuticals | 1.42B |
| Windward Bio Group AG | 1.41B |
| Nurix Therapeutics | 1.40B |
| Intellia Therapeutics | 1.40B |